Home / News (Page 2)

News

BIO€QUITY Europe, Paris May 22, 23

Invectys will attend to the 18th annual BIO€QUITY Europe Meet Invectys there ! More information:  invest@invectys.com 18TH ANNUAL BIO€QUITY EUROPE Bio€quity…

Read more

Invectys AT BIO-Europe Spring 2019, Vienna March 25th 2...

BIO-Europe Spring 2019 March 25th – 27th 2019 Messe Wien Exhibition and Congress Center, Vienna, Austria Invectys will be attending the BIO-Europe Spring 2019.…

Read more

Invectys at the AACR meeting in Atlanta, March 2019

Invectys will be attending the AACR Annual Meeting 2019, March 29 – Apr 3, 2019. Georgia World Congress Center Atlanta,  The AACR (American Association for…

Read more

Invectys secures €15 million equity financing

Invectys secures €15 million equity financing to advance lead program INVAC-1 into groundbreaking phase II clinical trial in CLL   Financing complements the…

Read more

Invectys at JP Morgan 37th Annual Healthcare Conference...

January 7 – 10, 2019 J.P. Morgan 37th Annual Healthcare Conference 2019 San-Francisco   The annual J.P. Morgan Healthcare Conference is the largest and most…

Read more

FDA approval to launch INVAC-1 Phase II clinical trial

Invectys announces FDA approval to launch a Phase II clinical trial of its therapeutic cancer vaccine INVAC-1 After a recent capital raise of 4.3 M€s another…

Read more

4,3 Millions d’Euros de levés pour initier la Phase II

After its Phase I success, Invectys raises €4.3 million to enter Phase II with both of its anti-cancer vaccines   Paris, July 12th, 2017 – This round brings…

Read more

Invectys presents its INVAC-1 therapeutic vaccine Phase...

Presentation of the Invectys clinical trial results on cancer patients at the most important worldwide oncology meeting taking place this year in Chicago, USA Paris,…

Read more